Arthropathies

MD Orthopaedics Publishes Clubfoot Chronicles, One Parent's Heartfelt and Personal Account of Life With a Clubfoot Child

Retrieved on: 
Thursday, July 8, 2021

Clubfoot Chroniclesoffers an honest and heartfelt look into the ups and downs of raising a clubfoot child.

Key Points: 
  • Clubfoot Chroniclesoffers an honest and heartfelt look into the ups and downs of raising a clubfoot child.
  • Upon hearing her daughter's clubfoot diagnosis, Maureen set out to find out as much as she could about the clubfoot defect and treatment options.
  • It is her hope that other clubfoot parents will benefit from her experiences, wisdom and research and have a smoother, easier clubfoot journey.
  • Maureen recently became a Brand Ambassador for MD Orthopaedics and is working with them to create supportive content for other clubfoot parents.

Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021

Retrieved on: 
Wednesday, May 19, 2021

ALIGN3D\xe2\x84\xa2 is a unique and comprehensive 5-year study, and we are pleased to report these positive interim results.

Key Points: 
  • ALIGN3D\xe2\x84\xa2 is a unique and comprehensive 5-year study, and we are pleased to report these positive interim results.
  • The primary effectiveness endpoint is radiographic recurrence of the hallux valgus deformity at 24 months follow up.
  • The study enrolled 173 patients, aged 14 to 58 years, at 7 clinical sites in the United States with 13 participating surgeons.
  • Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot.

Armis Biopharma Announces FDA Approval of VeriFixx™ Small Bone Implant

Retrieved on: 
Thursday, November 19, 2020

FORT COLLINS, Colo., Nov. 19, 2020 /PRNewswire/ --Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the VeriFixx Small Bone Implant for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe.

Key Points: 
  • FORT COLLINS, Colo., Nov. 19, 2020 /PRNewswire/ --Armis Biopharma, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the VeriFixx Small Bone Implant for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe.
  • VeriFixx is designed to make surgical corrections of this kind more accessible to patients through shorter time to ambulation, shorter overall recovery time and reduced pain.
  • "For patients requiring a small bone implant, the length of recovery and pain are common concerns," said Ted Ziemann, Chairman and CEO of Armis Biopharma.
  • In the U.S., there are approximately 500,000 small bone implant procedures each year.

Global Hallux Valgus (Bunion) Market Report 2020: Insight, Epidemiology and Market Forecast 2017-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 13, 2020

The "Hallux Valgus Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hallux Valgus Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'Hallux Valgus (Bunion)-Market Insights, Epidemiology and Market Forecast - 2030' report delivers an in-depth understanding of the Hallux Valgus, historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU-5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.
  • The Hallux Valgus market report provides current treatment practices, emerging drugs, Hallux Valgus market share of the individual therapies, current and forecasted Hallux Valgus market size from 2017 to 2030 segmented by seven major markets.
  • The Hallux Valgus epidemiology division provides the insights about historical and current Hallux Valgus patient pool and forecasted trend for each seven major countries.

Hammertoe Surgery Group of NYC is Now Offering Free Virtual & In Person Consultations

Retrieved on: 
Thursday, August 20, 2020

NEW YORK, Aug. 20, 2020 /PRNewswire-PRWeb/ --Hammertoe Surgery Group of NYC (located on the Upper East Side in Manhattan, NY) announced today that they will be offering complimentary virtual and in-person consultations for hammertoe surgery, bunion surgery, corn surgery, as well as 2nd opinions.

Key Points: 
  • NEW YORK, Aug. 20, 2020 /PRNewswire-PRWeb/ --Hammertoe Surgery Group of NYC (located on the Upper East Side in Manhattan, NY) announced today that they will be offering complimentary virtual and in-person consultations for hammertoe surgery, bunion surgery, corn surgery, as well as 2nd opinions.
  • Dr. Suzanne Levine, director of Hammertoe Surgery Group of NYC stated, "We fully acknowledge that in person foot surgery consultations may not be practical for some of our potential patients during Covid-19.
  • The Hammertoe Surgery Group of NYC is comprised of board-certified experienced podiatrists and foot surgeons who are leaders in the field of podiatry and who have been trained in world-renowned foot surgery training programs.
  • Our foot surgery specialists hold academic and clinical positions at some of the NYCs top universities and hospitals in Manhattan, New York.

Impressio Inc. and MedShape, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Joint Replacement Device

Retrieved on: 
Tuesday, July 28, 2020

Approximately 2.5% of people over 50 years old, which is roughly 2-3 million people in the U.S., develop hallux rigidus.

Key Points: 
  • Approximately 2.5% of people over 50 years old, which is roughly 2-3 million people in the U.S., develop hallux rigidus.
  • By exploiting the LCE's inherent dissipative and anisotropic behavior, Impressio and MedShape will collaboratively develop an MTP joint replacement that better replicates the structural and biomechanical function of native cartilage while also reducing wear.
  • The results of this work could also have broader potential use to treat arthritis in other joints in the foot, hand, and knee.
  • About Impressio, Inc.: Impressio Inc. is the first to develop a breakthrough in liquid crystal elastomers (LCEs) technology.

Nextremity Solutions, Inc. Receives FDA 510(k) Clearance for Cannulated Hammertoe System

Retrieved on: 
Friday, July 3, 2020

The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.

Key Points: 
  • The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.
  • The design of the cannulated implants and instruments provide targeting and technique guidance for repeatable outcomes.
  • Ryan Schlotterback, Chief Technology Officer for Nextremity Solutions said, "Nextremity Solutions was founded years ago by surgeons with a passion for the foot and ankle market and with an innovative solution for hammertoe correction.
  • The Nextremity Solutions DuoHex CH Cannulated Hammertoe System is indicated for small bone reconstruction limited to interphalangeal repair and fusion of the lesser toes.

Pinckney Michigan foot doctor and podiatrist Tomasz Biernacki discusses bunion & hammer toe non-surgery treatment vs. the need for surgery in Livingston County

Retrieved on: 
Monday, June 15, 2020

PINCKNEY, Mich., June 15, 2020 /PRNewswire-PRWeb/ -- Dr. Tomasz Biernacki states that "If bunion, hammer toe and flat foot formation can be caught relatively early, this will prevent permanent arthritis from developing.

Key Points: 
  • PINCKNEY, Mich., June 15, 2020 /PRNewswire-PRWeb/ -- Dr. Tomasz Biernacki states that "If bunion, hammer toe and flat foot formation can be caught relatively early, this will prevent permanent arthritis from developing.
  • Dr. Biernacki further states "It is estimated that the people who develop flat feet and bunion formation can have further knee pain, hip pain and lower back pain.
  • The podiatrists and foot doctors at Advanced Foot and Ankle Specialists of Pinckney Michigan have developed a treatment algorithm for diagnosing and treating bunion pain with both surgery and without surgery.
  • All podiatrists foot doctors are on staff at St. Joseph Mercy hospitals in Ann Arbor, Howell and Brighton Michigan.

OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System

Retrieved on: 
Thursday, March 12, 2020

OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts.

Key Points: 
  • OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts.
  • The OSSIOfiber Hammertoe Fixation System comprises the companys breakthrough OSSIOfiber Intelligent Bone Regeneration Technology, a new category of fixation material that combines unparalleled mechanical strength and natural bone healing in a non-permanent implant.
  • In 2019, OSSIO completed enrollment in its European multi-center clinical trial designed to assess the safety and performance of the OSSIOfiber Hammertoe Fixation System.
  • These findings will serve to support OSSIOs Conformit Europene (CE) Mark application for approval of the OSSIOfiber Hammertoe Fixation System later this year.

Miracle Flights: On the Road to Recovery, Michigan Twins Born with Clubfoot Celebrate First Birthday

Retrieved on: 
Thursday, December 12, 2019

The infant boys were born with clubfoot, a complex condition that causes their tiny feet to twist inward.

Key Points: 
  • The infant boys were born with clubfoot, a complex condition that causes their tiny feet to twist inward.
  • The national charity Miracle Flights has been flying the Brincat family free of charge to reach the specialized medical treatment that's giving the twins a leg up on healing.
  • Andrew and Isaac were diagnosed with clubfoot at 20 weeks gestation and born prematurely 15 weeks later.
  • On their neonatologist's recommendation, the twins began serial casting on their feet when they were just six weeks old.